Periconceptional use of folic acid to reduce the rates of neural tube defects: is it working?
Einarson
A
A
The Motherisk Program, Division of Clinical Pharmacology/Toxicology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. einarson@sickkids.on.ca
Parshuram
C
C
Koren
G
G
D000328:Adult; D002170:Canada / Q000453:epidemiology; D019587:Dietary Supplements; D005260:Female; D005492:Folic Acid / Q000008:administration & dosage*; D005527:Food, Fortified; D006801:Humans; D009436:Neural Tube Defects / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D016742:Preconception Care; D011247:Pregnancy; D011256:Pregnancy Outcome; D011295:Prenatal Care; D016032:Randomized Controlled Trials as Topic; D006113:United Kingdom
D005492:Folic Acid